U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology)- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. home infusion therapy market size was exhibited at USD 11.19 billion in 2022 and is projected to hit around USD 30.1 billion by 2032, growing at a CAGR of 10.4% during the forecast period 2023 to 2032.

https://www.novaoneadvisor.com/insightimg/US-Home-Infusion-Therapy-Market-Size.jpg

Key Pointers:

  • The infusion pumps segment held the largest revenue share of 52.8% in 2022.
  • The anti-infective segment registered a significant revenue share of 30.2% in 2022.
  • The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries.
  • Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Report Scope of the U.S. U.S. Home Infusion Therapy Market

Report Coverage

Details

Market Size in 2023

USD 12.35 Billion

Market Size by 2032

USD 30.1 Billion

Growth Rate from 2023 to 2032

CAGR of 10.4%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

Product, Application

 

The growing elderly population prone to various severe disorders is one of the major growth drivers for the industry. In addition, the increasing prevalence of disorders, such as cancer, diabetes, chronic pain, and gastrointestinal diseases is also expected to fuel the growth. The emergence of COVID-19 increased the importance and demand for medical devices especially in a home-based setting as the virus is transmitted through physical contact. The market witnessed positive revenue increases in 2020 but key players faced supply chain bottlenecks.

However, in 2021, key players like Baxter, Option Healthcare, and Smiths Medical reported a soaring revenue increase as compared to 2020, especially in the U.S. For instance, Baxter reported an eight percent increase in sales revenue in the third quarter of 2021 as compared to 2020. Growth of 14.9% ($ 892.9 million) was reported by Option Care Health Inc in the third quarter of 2021 as compared to $782.6 in 2020. This indicates that the market is recovering at a conspicuous rate and is expected to boost further.

The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market’s growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients’ preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

Some of the prominent players in the U.S. home infusion therapy Market include:

  • B. Braun Melsungen,
  • Baxter International,
  • Caesarea Medical Electronics Ltd.,
  • CareFusion,
  • Fresenius Kabi,
  • ICU Medical,
  • JMS CO., LTD.,
  • Smiths Medical, Inc.,
  • Terumo Corporation,
  • Coram LLC,
  • Option Care Enterprises, Inc.,
  • BioScrip, Inc.,
  • BriovaRx Infusion Services,
  • Paragon Healthcare.

Segments Covered in the Report

This report forecasts the volume and revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor has segmented the U.S. home infusion therapy market.

By Product 

  • Infusion pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

By Application 

  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Frequently Asked Questions

The U.S. home infusion therapy market size was exhibited at USD 11.19 billion in 2022 and is projected to hit around USD 30.1 billion by 2032

The U.S. home infusion therapy market is growing at a compound annual growth rate (CAGR) of 10.4% from 2023 to 2032.

Anti-Infective segment dominated the U.S. home infusion therapy market with a share of 30.2% in 2022. This is attributable to extensive use as antifungal, antibiotics, and antiviral agent at-home care.

Some key players operating in the U.S. home infusion therapy market include B. Braun Melsungen; Baxter International; Caesarea Medical Electronics Ltd.; CareFusion; Fresenius Kabi; ICU Medical; JMS CO., LTD.; Smiths Medical, Inc.; Terumo Corporation

Chapter 1. Introduction
                   1.1 Market Segmentation and Scope
                       1.1.1 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information procurement
                       1.3.1 Purchased database
                       1.3.2 Nova one advisor’s internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                           1.6.1.1 Approach 1: Commodity Flow Approach
                   1.7 List of Secondary Sources
                   1.8 Objectives
                       1.8.1 Objective 1
                       1.8.2 Objective 2
                       1.8.3 Objective 3
                       1.8.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Penetration & Growth Prospect Mapping
                   2.3 Market Dynamics
                       2.3.1 Market driver analysis
                           2.3.1.1 Increasing geriatric population
                           2.3.1.2 Rising prevalence of chronic disorders
                           2.3.1.3 Rapid technological advancements
                           2.3.1.4 Growing incidence of hospital-acquired infections
                           2.3.1.5 Home healthcare as a cost-effective alternative
                       2.3.2 Market restrain analysis
                           2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
                       2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2020.
                       2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
                   2.4 U.S. Home Infusion Therapy: Market Analysis Tools
                       2.4.1 Industry analysis - Porter’s Five Forces
                       2.4.2 PESTLE analysis
                   2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2020
                   2.6 Major Deals & Strategic Alliances Analysis
                   2.7 Procedure cost analysis/breakdown
                   2.8 Technology Timeline
                   2.9 Regulatory Framework
                   2.10 Reimbursement framework
Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2020 - 2030
                   3.1 Product Market Share Analysis, 2023 & 2030
                   3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
                   3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
                       3.3.1 Infusion pumps
                           3.3.1.1 Infusion Pumps Market, 2020 - 2030
                           3.3.1.2 Elastomeric Market, 2020 - 2030
                           3.3.1.3 Electromechanical Market, 2020 - 2030
                           3.3.1.4 Gravity Market, 2020 - 2030
                           3.3.1.5 Others Market, 2020 - 2030
                       3.3.2 Intravenous sets
                       3.3.3 Intravenous Sets Market, 2020 - 2030
                       3.3.4 Gravity Sets Market, 2020 - 2030
                       3.3.5 Dedicated Sets Market, 2020 - 2030
                       3.3.6 Iv Cannulas
                           3.3.6.1 Iv Cannulas Market, 2020 - 2030
                       3.3.7 Needleless Connectors
                           3.3.7.1 Needleless Connectors Market, 2020 - 2030
Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2020 - 2030
                   4.1 Application Market Share Analysis, 2023 & 2030
                   4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
                   4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
                       4.3.1 Anti-Infective
                           4.3.1.1 Anti-infective market, 2020 - 2030
                       4.3.2 endocrinology
                           4.3.2.1 Endocrinology Market, 2020 - 2030
                           4.3.2.2 Diabetes market, 2020 - 2030
                           4.3.2.3 Others market, 2020 - 2030
                       4.3.3 Hydration therapy
                           4.3.3.1 hydration therapy market, 2020 - 2030
                           4.3.3.2 Athletes market, 2020 - 2030
                           4.3.3.3 Others market, 2020 - 2030
                       4.3.4 Chemotherapy
                           4.3.4.1 Chemotherapy Market, 2020 - 2030
                       4.3.5 Enteral Nutrition
                           4.3.5.1 Enteral Nutrition Market, 2020 - 2030
                       4.3.6 Parenteral Nutrition
                           4.3.6.1 Parenteral Nutrition Market, 2020 - 2030
                       4.3.7 Specialty Pharmaceuticals
                           4.3.7.1 Specialty Pharmaceuticals Market, 2020 - 2030
                       4.3.8 Others
                           4.3.8.1 Others market, 2020 - 2030
Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2020 - 2030
                   5.1 Market Size, & Forecasts, and Trend Analysis, 2023 to 2030
                   5.2 U.S.
                       5.2.1 U.S. Home Infusion Therapy market, by product, 2020 - 2030
                       5.2.2 U.S. Home Infusion Therapy market, by application, 2020 - 2030
Chapter 6 Home Infusion Therapy Market - Competitive Analysis
                   6.1 Competitive Dashboard Analysis - Impact Analysis
                       6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
                   6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                       6.2.1 List of key innovators
                       6.2.2 List of market leaders
                       6.2.3 List of emerging players
                   6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
                       6.3.1 By Revenue
                   6.4 Strategy Framework
                   6.5 Company Profiles
                       6.5.1 B. Braun Melsungen AG
                           6.5.1.1 Company overview
                           6.5.1.2 Financial performance
                           6.5.1.3 Product benchmarking
                           6.5.1.4 Strategic initiatives
                       6.5.2 Baxter
                           6.5.2.1 Company overview
                           6.5.2.2 Financial performance
                           6.5.2.3 Product benchmarking
                           6.5.2.4 Strategic initiatives
                       6.5.3 Caesarea Medical Electronics
                           6.5.3.1 Company overview
                           6.5.3.2 Product benchmarking
                           6.5.3.3 Strategic initiatives
                       6.5.4 CareFusion Corporation
                           6.5.4.1 Company overview
                           6.5.4.2 Financial performance
                           6.5.4.3 Product benchmarking
                           6.5.4.4 Strategic initiatives
                       6.5.5 Fresenius Kabi AG
                           6.5.5.1 Company overview
                           6.5.5.2 Financial performance
                           6.5.5.3 Product benchmarking
                           6.5.5.4 Strategic initiatives
                       6.5.6 ICU Medical, Inc.
                           6.5.6.1 Company overview
                           6.5.6.2 Financial performance
                           6.5.6.3 Product benchmarking
                           6.5.6.4 Strategic initiatives
                       6.5.7 JMS Co., Ltd.
                           6.5.7.1 Company overview
                           6.5.7.2 Financial performance
                           6.5.7.3 Product benchmarking
                       6.5.8 Smiths Medical
                           6.5.8.1 Company overview
                           6.5.8.2 Financial performance
                           6.5.8.3 Product benchmarking
                           6.5.8.4 Strategic initiatives
                       6.5.9 Terumo Corporation
                           6.5.9.1 Company overview
                           6.5.9.2 Financial performance
                           6.5.9.3 Product benchmarking
                           6.5.9.4 Strategic initiatives
                       6.5.10 Coram LLC
                           6.5.10.1 Company overview
                           6.5.10.2 Product benchmarking
                       6.5.11 Option Care Enterprises, Inc.
                           6.5.11.1 Company overview
                           6.5.11.2 Financial performance
                           6.5.11.3 Product benchmarking
                           6.5.11.4 Strategic initiatives
                       6.5.12 BioScrip, Inc.
                           6.5.12.1 Company overview
                           6.5.12.2 Financial performance
                           6.5.12.3 Product benchmarking
                           6.5.12.4 Strategic initiatives
                       6.5.13 BriovaRx Infusion Services
                           6.5.13.1 Company overview
                           6.5.13.2 Financial performance
                           6.5.13.3 Product benchmarking
                           6.5.13.4 Strategic initiatives
                   6.6. Paragon Healthcare, Inc.
                       6.6.1 Company overview
                       6.6.2 Financial performance
                       6.6.3 Product benchmarking

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers